MedWatch

Eli Lilly to raise millions for green initiatives

By pricing the sustainability bonds, US-based pharmaceutical company Eli Lilly hopes to raise millions for its ESG objectives.

Photo: Mike Blake/REUTERS / X00030

Regardless of whether you call them green, sustainable or ESG bonds – what it comes down to is the same thing: raising money for green initiatives.

That is exactly what Eli Lilly wants to achieve by issuing what they call "sustainability bonds". The US-based company intends to raise USD 600m (DKK 3.8bn) through the pricing of the bonds.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs